Results 1 - 20 of 250 in Gilead Sciences
-
AIDS Drugs Trigger Inflammation Linked to Diabetes, Australian Study Shows
... why some HIV sufferers are more likely to develop diabetes and heart disease, doctors in Australia said. Gilead Sciences Inc. a s Truvada and other medicines known as nucleoside reverse transcriptase inhibitors prompt fat cells to release ...
Comment?
-
Teva in bid to make generic version of Gilead's AIDS drug Truvada
AIDS drug maker Gilead Sciences Inc has said that Teva Pharmaceutical Industries Ltd intends to make a generic version of its top-selling drug Truvada.
Comment?
-
Public relations, press release distribution, investor relations, SEC filing
FOSTER CITY, Calif.-- --Gilead Sciences, Inc. today announced receipt of a Paragraph IV Certification Notice Letter advising that Teva Pharmaceuticals submitted - BOSTON-- --Converted Organics Inc.
Comment?
-
After Hours: Gilead Sciences, Motorola shares lower in evening session
Gilead Sciences Inc. shares fell late Friday after word that another drug company wants to manufacture a generic version of its HIV drug.
Comment?
-
Gilead Sciences Announces Notification of ANDA Filing for Truvada
Gilead Sciences Announces Notification of ANDA Filing for Truvada FOSTER CITY, Calif.-- --Gilead Sciences, Inc.
Comment?
-
Gilead mulls patent fight with Teva
Gilead Sciences Inc. will study an application made by rival Teva Pharmaceuticals to the FDA for a generic version of the HIV drug Truvada, and decide within 45 days whether to file a patent suit.
Comment?
-
Gilead Sciences, Inc. To Appeal FDA Cystic Fibrosis Trial Demand
Gilead Sciences Inc plans to appeal a request by the U.S. Food and Drug Administration for an additional clinical study of the company's experimental cystic fibrosis drug, a spokeswoman said on Thursday.
Comment?
-
Gilead Sciences to Present at Three Upcoming Investor Conferences
Patrick O'Brien, 650-522-1936 Gilead Sciences, Inc. announced today that the company will be webcasting its corporate presentation at three upcoming investor conferences: Rodman & Renshaw 10th Annual Healthcare ...
Comment?
-
Gilead Sciences, Inc. (Nasdaq:GILD) Xplosive Stock on the Move
XplosiveStocks.com tracks daily stocks that are on the move like Gilead Sciences, Inc.
Comment?
-
Gilead Sciences to Present at Three Upcoming Investor Conferences
FOSTER CITY, Calif.-- --Gilead Sciences, Inc. announced today that the company will be webcasting its corporate presentation at three upcoming investor conferences: Rodman & Renshaw 10 th th Annual Credit ...
Comment?
-
Gilead Announces Two-Year Data from Pivotal Phase III Studies...
Nov. 1, 2008--Gilead Sciences, Inc. today announced the presentation of two-year data from two Phase III pivotal clinical trials, Studies 102 and 103, evaluating the safety and efficacy of once-daily Viread ...
Comment?
-
Gilead Announces Two-Year Data from Pivotal Phase III Studies...
Susan Hubbard, 650-522-5715 Michael Claeys, 650-522-2459 Gilead Sciences, Inc. today announced the presentation of two-year data from two Phase III pivotal clinical trials, Studies 102 and 103, evaluating the ...
Comment?
-
Gilead tests rival with pulmonary disease drug
... patients with a rare, deadly malady are up for grabs, with two Bay Area companies staking out market share. Gilead Sciences Inc. of Foster City and Actelion Ltd., a Swiss biotech with U.S. headquarters in South San Francisco, are rolling out ...
Comment?
-
New developments test city's water needs
... Monday a Water Supply Assessment Report that indicates the city will have enough water to support the new Gilead Sciences campus, the Mirabella Parkview Plaza project and offices near the intersection of Chess and Hatch drives. State law requires ...
Comment?
-
CU gets $5 million from former Myogen CEO and wife
... and have been exploring inhalable vaccines. Myogen is a CU-based biotechnology startup that was acquired by Gilead Sciences Inc. for $2.5 billion.
Comment?
-
CU grad gives $5 million to university
... and have been exploring inhalable vaccines. Myogen is a CU-based biotechnology startup that was acquired by Gilead Sciences Inc. for $2.5 billion. Don't Miss It First Alert Doppler . It's the only radar in Southern Colorado that's truly live. Find ...
Comment?
-
Gilead Sciences to Present at the Oppenheimer 19th Annual Healthcare...
Patrick O'Brien, 650-522-1936 Gilead Sciences, Inc. today announced that its corporate presentation will be webcast from the Oppenheimer 19th Annual Healthcare Conference in New York.
Comment?
-
EFI Reaches Agreement to Sell Real Estate Assets
EFI has reached an agreement to sell a portion of its Foster City, CA campus for $137.5 million to Gilead Sciences, Inc.
Comment?
-
Alexandria Real Estate Equities, Inc. Reports Third Quarter 2008 Operating and Financial Results
... Feet of Redevelopment and Development Space Year-to-Date 2008 - Executed 106,000 Square Foot Lease with Gilead Sciences, Inc. in Seattle, Washington - Executed 47,000 Square Foot Lease with Novartis Institutes for Biomedical Research, Inc. in ...
Comment?
-
GlaxoSmithKline buys Genelabs for $57M
... overall contract revenue following the conclusion of the research phase of the company's collaboration with Gilead Sciences Inc. (NASDAQ:GILD), Genelabs said.
Comment?
Gilead Sciences Forum
Most Popular
